HuR: a promising therapeutic target for angiogenesis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Angiogenesis, the formation of new blood vessels, is crucial in diseases like cancer and ischemia.
• Posttranscriptional regulation via mRNA untranslated regions is a key biological control mechanism.
• HuR (Human antigen R) is an RNA-binding protein involved in stabilizing messenger RNAs.

Purpose of the Study:

• To explore the role of HuR in angiogenesis.
• To investigate HuR as a potential therapeutic target for angiogenesis-related diseases.
• To evaluate HuR's implication in hypoxia and inflammatory responses.

Main Methods:

• Analysis of HuR's function in stabilizing angiogenic factors.
• Investigating HuR's role in endothelial cell proliferation and migration.
• Examining HuR's involvement in hypoxia and inflammatory signaling pathways.

Main Results:

• HuR augments hypoxic and inflammatory signals, stabilizing angiogenic factors.
• HuR promotes endothelial cell proliferation and migration, contributing to angiogenesis.
• HuR is implicated in HuR-mediated angiogenesis under hypoxic and inflammatory conditions.

Conclusions:

• HuR plays a critical role in proangiogenic factor-mediated angiogenesis.
• Targeting HuR may enhance therapeutic angiogenesis and block tumor angiogenesis.
• HuR represents a promising therapeutic target for angiogenesis-related diseases, including cancer and hypoxia therapy.